BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6968619)

  • 1. Monoamine replacement after reserpine: catecholaminergic agonists restore motor activity but phenylethylamine restores atropine-resistant neocortical low voltage fast activity.
    Vanderwolf CH; Robinson TE; Pappas BA
    Brain Res; 1980 Nov; 202(1):65-77. PubMed ID: 6968619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reserpine abolishes movement-correlated atropine-resistant neocortical low voltage fast activity.
    Vanderwolf CH; Pappas BA
    Brain Res; 1980 Nov; 202(1):79-94. PubMed ID: 7427747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic self-stimulation: the role of dopamine and possible relations to neocortical slow wave activity.
    Vanderwolf CH; Gutman M; Baker GB
    Behav Brain Res; 1984 Apr; 12(1):9-19. PubMed ID: 6732919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors.
    Jackson DM
    Arzneimittelforschung; 1975 Apr; 25(4):622-6. PubMed ID: 168908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between a novel cholinergic ion channel agonist, SIB-1765F and L-DOPA in the reserpine model of Parkinson's disease in rats.
    Menzaghi F; Whelan KT; Risbrough VB; Rao TS; Lloyd GK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):393-401. PubMed ID: 8996220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation on the behavioral and hypothermic effects of yohimbine: interaction with drugs affecting central and peripheral monoamines.
    Papeschi R
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):61-80. PubMed ID: 4276928
    [No Abstract]   [Full Text] [Related]  

  • 7. Clonidine antinociceptive activity: effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat.
    Paalzow G; Paalzow L
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):119-26. PubMed ID: 133292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Effect of 3,4-dimethoxyphenethylamine on monoamine-depleted rats.
    Prepas S; Menon MK; Clark WG
    J Pharm Pharmacol; 1973 Aug; 25(8):659-60. PubMed ID: 4148440
    [No Abstract]   [Full Text] [Related]  

  • 9. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
    Biggs CS; Fisher A; Starr MS
    Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats.
    Lee J; Di Marzo V; Brotchie JM
    Neuropharmacology; 2006 Sep; 51(3):557-65. PubMed ID: 16806299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1993; 45(4):349-60. PubMed ID: 7906989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central action of phenylethylamine in rats.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1981; 33(1):59-71. PubMed ID: 7196039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex.
    Dereń-Wesołek A; Maj J
    Pol J Pharmacol; 1993; 45(5-6):467-80. PubMed ID: 7912135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that serotonin mediates non-cholinergic neocortical low voltage fast activity, non-cholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior.
    Vanderwolf CH; Baker GB
    Brain Res; 1986 May; 374(2):342-56. PubMed ID: 2941111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tryptaminergic and dopaminergic responses of Schistosoma mansoni.
    Tomosky TK; Bennett JL; Bueding E
    J Pharmacol Exp Ther; 1974 Aug; 190(2):260-71. PubMed ID: 4155765
    [No Abstract]   [Full Text] [Related]  

  • 16. Electroconvulsive shock and postsynaptic catecholamine effects: increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS.
    Modigh K
    J Neural Transm; 1975; 36(1):19-32. PubMed ID: 164522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked locomotor stimulation in monoamine-depleted mice following treatment with atropine in combination with clonidine.
    Carlsson M; Carlsson A
    J Neural Transm Park Dis Dement Sect; 1989; 1(4):317-22. PubMed ID: 2557047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of LSD-25, clonidine and apomorphine on copulatory behavior in the male rat.
    Malmnäs CO
    Acta Physiol Scand Suppl; 1973; 400():96-116. PubMed ID: 4527035
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergism of imipramine and desmethylimipramine with reserpine in the frog. Interaction with 5-hydroxytryptophan and 2-bromolysergid diethylamide (BOL-148).
    Lapin IP; Osipova SV; Uskova NV; Stabrovski EM
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):37-49. PubMed ID: 5303117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.